쿼드메디슨

464490KOSDAQ기초 의약물질 제조업

34.5 / 100

Reference Date: 2026-04-13

Financial Score10.0 / 40

News Sentiment12.5 / 25

Momentum2.0 / 20

Disclosure10.0 / 15

AI Analysis: the high debt ratio poses financial risk, PBR raises overvaluation concerns. Plunged 20.6% over the past month, and news sentiment is neutral.

Company InformationBased on 2025 Annual Report

Business Overview

QuadMedison develops next-generation drug delivery systems using micro needle platform technology, expanding its business through Contract Development and Manufacturing Organization (CDMO) agreements with pharmaceutical companies. The company's core technologies, including S-MAP, C-MAP, and P-MAP, enhance medication compliance and offer innovative solutions for vaccines and synthetic pharmaceuticals.

Number of Employees

90people

Average Salary

51.2M KRW

Score Calculation Basis

Detailed Financial Score

PER

—Industry Average 33.454.0Point

PBR

4.90Industry Average 2.030.0Point

2.4x industry avg (risky)

ROE

-32.69Industry Average -4.293.5Point

7.6x industry avg (excellent)

Debt Ratio

31.04Industry Average 6.610.0Point

4.7x industry avg (risky)

Trend 2024~20252.5 / 10 points

Revenue Growth Rate

2.5 / 3

Avg ▲15.0% (1-year basis)

Operating Profit Growth Rate

0.0 / 3

Avg ▼43.5% (1-year basis)

ROE Trend

0.0 / 4

Avg ROE -40.5% (improving, 2yr)

Detailed News Sentiment

2 totalPositive 0Neutral 1Negative 0Average Sentiment Score 50

Neutral
스파크랩, 대국민 창업 오디션 '모두의 창업' 운영기관에 선정
스파크랩이 중소벤처기업부 주관 대국민 창업 오디션 '모두의 창업' 운영기관으로 선정되어 창업 도전자를 선발합니다.

Detailed Momentum

52-week position1.0Point

Near 52w low (3%, downtrend)

Current 13,150Won52-week high 24,55052-week low 12,710

1-month return0.0Point

1m -20.64% (strong drop)

Volume trend1.0Point

Volume decreasing

Detailed Disclosure

3 totalPositive 0Neutral 3Negative 0

Neutral정기주주총회결과2026-03-30
Neutral감사보고서제출2026-03-20
Neutral사업보고서 (2025.12)2026-03-20